Net profit of Pfizer rose 85.03% to Rs 330.94 crore in the quarter ended March 2025 as against Rs 178.86 crore during the previous quarter ended March 2024. Sales rose 8.28% to Rs 591.91 crore in the quarter ended March 2025 as against Rs 546.63 crore during the previous quarter ended March 2024.
For the full year,net profit rose 39.23% to Rs 767.60 crore in the year ended March 2025 as against Rs 551.33 crore during the previous year ended March 2024. Sales rose 4.02% to Rs 2281.35 crore in the year ended March 2025 as against Rs 2193.17 crore during the previous year ended March 2024.
| Particulars | Quarter Ended | Year Ended |
| Mar. 2025 | Mar. 2024 | % Var. | Mar. 2025 | Mar. 2024 | % Var. |
| Sales | 591.91 | 546.63 | 8 | 2281.35 | 2193.17 | 4 |
| OPM % | 38.43 | 34.65 | - | 32.45 | 28.97 | - |
| PBDT | 269.39 | 257.61 | 5 | 904.07 | 800.40 | 13 |
| PBT | 252.99 | 243.86 | 4 | 843.28 | 738.12 | 14 |
| NP | 330.94 | 178.86 | 85 | 767.60 | 551.33 | 39 |